ABSTRACT
Treatment of age-related macular degeneration (AMD)-associated choroidal neovascularization (CNV) by photocoagulation of the vessel-or vessels-supplying blood to the CNV has long been considered an attractive approach, particularly when the neovascularization is very near or underlies the fovea. Although elegantly simple as a concept, successfully implementing this treatment approach has proven to be a protracted process. The history of its development spans a period of nearly 30 years, and the case can be made its development has been coupled to the evolution of fundus angiography technology, especially choroidal angiography.
